Pharmacokinetic Profiles of a Biosimilar Filgrastim and Amgen Filgrastim: Results From a Randomized, Phase I Trial
Annals of Hematology - Germany
doi 10.1007/s00277-010-0961-x
Full Text
Open PDFAbstract
Available in full text
Date
April 29, 2010
Authors
Publisher
Springer Science and Business Media LLC